A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial.

Saved in:
Bibliographic Details
Title: A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial.
Authors: Beyer E; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia., Skumlien M; Department of Social, Genetic & Developmental Psychiatry Centre (SGDP), Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Poudel G; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia.; Braincast Neurotechnologies, Melbourne, VIC, Australia., Arun AH; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.; Centre of Advanced Imaging Australia Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Queensland, Australia., McTavish E; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia., Thomson H; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia., Sehl H; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia., Segrave R; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia., Clemente A; School of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia., Labuschagne I; School of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.; School of Psychology, University of Queensland, Brisbane, QLD, Australia., Rendell P; School of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia.; School of Psychology, University of Queensland, Brisbane, QLD, Australia., Terrett G; School of Behavioural & Health Sciences, Australian Catholic University, Fitzroy, VIC, Australia., Greenwood LM; School of Medicine and Psychology, Australian National University College of Health and Medicine, The Australian National University, Canberra, Australia., Manning V; Eastern Health, Turning Point, Monash University, Melbourne, VIC, Australia., Freeman TP; Department of Psychology, Addiction and Mental Health Group (AIM), University of Bath, Bath, UK., Kamboj SK; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, London, UK., Suo C; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia.; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia.; School of Psychology, University of Queensland, Brisbane, QLD, Australia.; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lorenzetti V; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Level 5 Daniel Mannix Building, 115 Victoria Parade, Fitzroy, VIC, Australia. valentina.lorenzetti@gmail.com.; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, London, UK. valentina.lorenzetti@gmail.com.
Source: Psychopharmacology [Psychopharmacology (Berl)] 2026 May 07. Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-2072
DOI:10.1007/s00213-026-07073-0